Neil F. McFarlane
President and CEO at Zevra Therapeutics · 8 reported transactions in 1 company · latest trade Oct 12, 2026
Their trades
Sold | Oct 12, 2026 | Oct 12, 2026 close $11.32 → Oct 29, 2026 close $10.36. S&P 500 −0.7% over the same days. | ||
Sold | Feb 9, 2026 | Feb 9, 2026 close $8.57 → Oct 29, 2026 close $10.36. S&P 500 +11.3% over the same days. | ||
Sold | Feb 2, 2026 | Feb 2, 2026 close $9.36 → Oct 29, 2026 close $10.36. S&P 500 +11.1% over the same days. | ||
Sold | Oct 10, 2025 | Oct 10, 2025 close $11.01 → Oct 29, 2026 close $10.36. S&P 500 +18.3% over the same days. |
$224.9K
Oct 12, 2026 close $11.32 → Oct 29, 2026 close $10.36. S&P 500 −0.7% over the same days.
$125.2K
Feb 9, 2026 close $8.57 → Oct 29, 2026 close $10.36. S&P 500 +11.3% over the same days.
$853.4K
Feb 2, 2026 close $9.36 → Oct 29, 2026 close $10.36. S&P 500 +11.1% over the same days.
$210.9K
Oct 10, 2025 close $11.01 → Oct 29, 2026 close $10.36. S&P 500 +18.3% over the same days.